clinicopathologic features
Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
9
EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
9
Original Article Clinicopathologic features of hemangioblastomas with emphases of unusual locations
9
Original Article Impact of Hashimotoas thyroiditis on clinicopathologic features of papillary thyroid carcinoma associated with infiltration of tumor-infiltrating lymphocytes
10
Original Article Clinicopathologic features of ovarian carcinosarcoma: a report of 17 cases
7
Original Article Clinicopathologic features of Stewart-Treves syndrome
9
Research progress of the clinicopathologic features of lung adenosquamous carcinoma
7
CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms
11
Clinicopathologic features of remnant gastric cancer after curative distal gastrectomy according to previous reconstruction method: a retrospective cohort study
9
Clinicopathologic Features and Early Surgical Outcome of Astrocytomas in Eldoret, Kenya.
7
Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
5
Subcutaneous Granuloma Annulare in Childhood: Clinicopathologic Features in 34 Cases
6
Original Article Clinicopathologic features of ovarian Sertoli-Leydig cell tumors
9
Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma
6
The expression of mir-126 associated with clinicopathologic features In gastric carcinoma
8
Determining the Clinicopathologic Features of Breast Lesions in Iranian Army Families
7
Clinicopathologic features of colorectal carcinoma: features predicting higher T stage and nodal metastasis
6
Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
6
Epidemiologic and Clinicopathologic Features of Advanced Hepatocellular Carcinoma
11
Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer
7